http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 05 Mar 2026 16:29:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26119392.html si-local-file:///var/storage/secattach/20260305/26119392.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26119392.html Thu, 05 Mar 2026 16:29:00 -0500 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26119392.html si-local-file:///var/storage/secattach/20260305/26119392.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26119392.html Thu, 05 Mar 2026 16:29:00 -0500 O.06012263 TNDM http://www.streetinsider.com/Corporate+News/Tandem+Diabetes+expands+Mobi+insulin+pump+to+Android+smartphones/26112475.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) announced that its Tandem Mobi automated insulin delivery system now supports compatible Android smartphones in the United States through the Tandem Mobi mobile app.</p><p>The U.S. Food and Drug Administration cleared the Android version of the mobile app in November 2025, followed by a limited release in December 2025. The app is available on Google Play for compatible devices including Google Pixel models 6 through 10 and Samsung Galaxy models S21 through S25.</p><p>Tandem Mobi initially launched with iPhone compatibility in 2024. The system uses Control-IQ+ technology and is designed as a small insulin pump that http://www.streetinsider.com/Corporate+News/Tandem+Diabetes+expands+Mobi+insulin+pump+to+Android+smartphones/26112475.html Wed, 04 Mar 2026 17:03:11 -0500 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Press+Releases/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html <p class="bwalignc"> Tandem Diabetes Care expands connected-care ecosystem by adding Android platform </p> <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260304073769/en/" rel="nofollow">https://www.businesswire.com/news/home/20260304073769/en/</a></p><div id="bwbodyimg" style="width: 292px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260304073769/en/2738191/4/Tandem_Mobi_Android_Product_Hero_A_821x1350_%281%29.jpg" alt="Tandem Mobi Now Compatible with Android Smartphones in U.S." /><p style="font-size:85%;">Tandem Mobi Now Compatible with Android Smartphones http://www.streetinsider.com/Business+Wire/Tandem+Mobi+Now+Compatible+with+Android+Smartphones/26112400.html Wed, 04 Mar 2026 17:00:00 -0500 A.06822034 A.20111752 O.06012263 O.15116613 O.20026344 TNDM http://www.streetinsider.com/Analyst+PT+Change/Tandem+Diabetes+Care+%28TNDM%29+PT+Raised+to+%2425+at+Morgan+Stanley/26087514.html Morgan Stanley analyst Patrick Wood raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $25.00 (from $23.00) while maintaining a Equalweight rating. http://www.streetinsider.com/Analyst+PT+Change/Tandem+Diabetes+Care+%28TNDM%29+PT+Raised+to+%2425+at+Morgan+Stanley/26087514.html Mon, 02 Mar 2026 08:18:28 -0500 TNDM http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TANDEM+DIABETES+CARE++++++For%3A+Feb+23/26081607.html si-local-file:///var/storage/secattach/20260227/26081607.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TANDEM+DIABETES+CARE++++++For%3A+Feb+23/26081607.html Fri, 27 Feb 2026 16:08:00 -0500 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TANDEM+DIABETES+CARE++++++For%3A+Feb+23/26081607.html si-local-file:///var/storage/secattach/20260227/26081607.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TANDEM+DIABETES+CARE++++++For%3A+Feb+23/26081607.html Fri, 27 Feb 2026 16:08:00 -0500 O.06012263 TNDM http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) announced the pricing of $265 million in convertible senior notes due 2032, increasing from a previously announced $200 million offering. The diabetes technology company said the notes will carry a 0.00% interest rate and mature on March 15, 2032.</p> <p>The company granted initial purchasers an option to buy up to an additional $35 million in notes within 13 days of issuance. The sale is expected to close on February 27, 2026, subject to customary closing conditions.</p> <p>Tandem estimates net proceeds of approximately $256.7 million, or $290.7 million if the full option is exercised, after deducting discounts http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html Wed, 25 Feb 2026 00:30:14 -0500 A.50211695 O.00562404 O.06012263 TNDM http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) announced the pricing of $265 million in convertible senior notes due 2032, increasing from a previously announced $200 million offering. The diabetes technology company said the notes will carry a 0.00% interest rate and mature on March 15, 2032.</p> <p>The company granted initial purchasers an option to buy up to an additional $35 million in notes within 13 days of issuance. The sale is expected to close on February 27, 2026, subject to customary closing conditions.</p> <p>Tandem estimates net proceeds of approximately $256.7 million, or $290.7 million if the full option is exercised, after deducting discounts http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html Wed, 25 Feb 2026 00:30:14 -0500 A.50211695 O.00562404 O.06012263 TNDM http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) announced the pricing of $265 million in convertible senior notes due 2032, increasing from a previously announced $200 million offering. The diabetes technology company said the notes will carry a 0.00% interest rate and mature on March 15, 2032.</p> <p>The company granted initial purchasers an option to buy up to an additional $35 million in notes within 13 days of issuance. The sale is expected to close on February 27, 2026, subject to customary closing conditions.</p> <p>Tandem estimates net proceeds of approximately $256.7 million, or $290.7 million if the full option is exercised, after deducting discounts http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html Wed, 25 Feb 2026 00:30:14 -0500 A.50211695 O.00562404 O.06012263 TNDM http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) announced the pricing of $265 million in convertible senior notes due 2032, increasing from a previously announced $200 million offering. The diabetes technology company said the notes will carry a 0.00% interest rate and mature on March 15, 2032.</p> <p>The company granted initial purchasers an option to buy up to an additional $35 million in notes within 13 days of issuance. The sale is expected to close on February 27, 2026, subject to customary closing conditions.</p> <p>Tandem estimates net proceeds of approximately $256.7 million, or $290.7 million if the full option is exercised, after deducting discounts http://www.streetinsider.com/Equity+Offerings/Tandem+Diabetes+Care+prices+%24265M+convertible+notes+offering/26054033.html Wed, 25 Feb 2026 00:30:14 -0500 A.50211695 O.00562404 O.06012263 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Prices+Upsized+Private+Placement+of+%24265+Million+of+Convertible+Senior+Notes+Due+2032/26054032.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $200.0 million aggregate principal amount of notes. Tandem also granted the initial purchasers of the notes an option to purchase, within http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Prices+Upsized+Private+Placement+of+%24265+Million+of+Convertible+Senior+Notes+Due+2032/26054032.html Wed, 25 Feb 2026 00:30:00 -0500 A.50211695 O.00562404 O.06012263 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Prices+Upsized+Private+Placement+of+%24265+Million+of+Convertible+Senior+Notes+Due+2032/26054032.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $200.0 million aggregate principal amount of notes. Tandem also granted the initial purchasers of the notes an option to purchase, within http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Prices+Upsized+Private+Placement+of+%24265+Million+of+Convertible+Senior+Notes+Due+2032/26054032.html Wed, 25 Feb 2026 00:30:00 -0500 A.50211695 O.00562404 O.06012263 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Prices+Upsized+Private+Placement+of+%24265+Million+of+Convertible+Senior+Notes+Due+2032/26054032.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $200.0 million aggregate principal amount of notes. Tandem also granted the initial purchasers of the notes an option to purchase, within http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Prices+Upsized+Private+Placement+of+%24265+Million+of+Convertible+Senior+Notes+Due+2032/26054032.html Wed, 25 Feb 2026 00:30:00 -0500 A.50211695 O.00562404 O.06012263 TNDM